Carsten Denkert

Researcher Next ID · RN-002026

Researcher · Biochemistry, Genetics and Molecular Biology

Frankfurt am Main, Germany

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Breast Cancer Treatment Studies

HER2/EGFR in Cancer Research

Cancer Immunotherapy and Biomarkers

Cancer Genomics and Diagnostics

Advanced Breast Cancer Therapies

Pembrolizumab for Early Triple-Negative Breast Cancer
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1910549
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30904-x
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
Annals of Oncology · 2014 · https://doi.org/10.1093/annonc/mdu450
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.38.8595
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Breast Cancer Research and Treatment · 2009 · https://doi.org/10.1007/s10549-009-0674-9

No projects listed.